Julie Khlevner, MD

Expertise in: 
Gastroenterology
Board Certifications: 
Pediatrics, Pediatric Gastroenterology
Accepting New Patients
Treats Children
Virtual Visits/Telehealth
Profile Headshot

Overview

I am privileged to have achieved my lifelong goal of becoming a pediatric gastroenterologist, more specifically a pediatric neurogastroenterologist. I have a special interest and expertise in disorders of the gut-brain interaction, including motility disorders, which involve the movement of food through the GI tract, and functional disorders, which involve interactions between the brain and GI tract that affect motility. These conditions can be debilitating and yet they remain challenging to treat effectively.

My team and I evaluate and treat children and adolescents using advanced, state-of-the-art diagnostic and therapeutic techniques with multidisciplinary approach. Some of the conditions we treat are dysphagia, achalasia, gastroesophageal reflux disease, chronic nausea, gastroparesis, irritable bowel syndrome, chronic abdominal pain, severe constipation, fecal incontinence, and anorectal disorders.

We think of our patients and their problems holistically and take pride in developing personal connections with patients and their families. My goal is to deliver compassionate, respectful, evidence-based, and humanistic care to children with gastrointestinal diseases.

I co-direct many multidisciplinary clinics, including the Gastrointestinal Motility Center, Esophageal Atresia Clinic, Aerodigestive Program, and Congenital Diaphragmatic Hernia Program, and I work closely with pediatric surgeons, pulmonologists, cardiologists, ear nose throat (ENT) specialists, psychologists, and language pathologists to provide the most comprehensive care to children with complex GI medical conditions.

I also take great pride in educating medical students, residents, fellows, and other providers. I have mentored several GI fellows who have joined other institutions across the county and are currently working to establish multidisciplinary clinics and expand access to care for functional and motility disorders.

In addition to my clinical and education roles, my team and I conduct multiple clinical research projects focusing on functional and motility disorders. I work on clinical trials which allow our patients to have access to therapeutics that are not otherwise offered to children. This work has led to numerous presentations at national meetings and publications in high impact gastroenterology journals—all with the mission of improving children’s health and advancing the science of gastrointestinal motility and functional gastrointestinal diseases.


Areas of Expertise / Conditions Treated

  • Abdominal Pain
  • Bowel Problems
  • Constipation
  • Encopresis
  • Esophageal Atresia
  • Gastroesophageal Reflux Disease
  • Gastrointestinal Disorders
  • Irritable Bowel Syndrome (IBS)
  • Motility Disorder, Esophageal
  • Motility disorders of the bowel
  • Pediatric Gastrointestinal (GI) Endoscopy

Academic Appointments

  • Associate Professor of Pediatrics at CUMC

Administrative Titles

  • Director, Pediatric Gastrointestinal Motility Center

Hospital Affiliations

  • NewYork-Presbyterian Morgan Stanley Children's Hospital
  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Female

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Internship: Jacobi Hospital - Albert Einstein College of Medicine
  • Residency: Jacobi Hospital - Albert Einstein College of Medicine
  • Fellowship: Stony Brook University Medical Center

Board Certifications

  • Pediatrics
  • Pediatric Gastroenterology

Honors & Awards

New York SuperDoctors Rising Star

Research

Clinical Trials

NCT02559570 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

NCT02559817 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, A Multicenter, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation (IBS-C) (ie, Fulfill Rome III Criteria for Child/Adolescent IBS and Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation

COMPLETED

NCT02042183 A Multicentre, Randomised, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation

NCT02138136 A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation